FDA seeks stronger warnings for Amylin's Byetta (Reuters)

[feedbot]

FDA seeks stronger warnings for Amylin's Byetta (Reuters)

Reuters - U.S. health regulators are seeking
stronger warnings about the risk of pancreatitis after the
deaths of two patients taking Amylin Pharmaceuticals Inc's
injectable diabetes drug Byetta, sending the company's shares
down as much 16 percent.

http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/amylin_byetta_dc.html